New FDA-Approved Treatment for RKD

The FDA has approved Ultomiris for adults with IgA Nephropathy (IgAN). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Lisa Cimino

Community Leader

Lisa has volunteered in various capacities with NephCure for over 18 years. Her kidney disease journey began 22 years ago when her daughter, Brianna, was diagnosed with Minimal Change Nephrotic Syndrome at only 2 years old. NephCure has been an amazing support system for over 20 years and Lisa is happy to give back to others who walk this challenging road.

NephCure Email: lisacimino@nephcurevolunteer.org

Massachusetts

Related News

NEWS

The FDA Grants Accelerated Approval of ULTOMIRIS (ravulizumab-cwvz) for Adults with IgA Nephropathy 

NEWS

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.